ScinoPharm Taiwan Ltd
TWSE:1789
ScinoPharm Taiwan Ltd's latest stock split occurred on Aug 10, 2017
The company executed a 26-for-25 stock split, meaning that for every 25 shares held, investors received 26 new shares.
Before the split, ScinoPharm Taiwan Ltd traded at 40.508 per share. Afterward, the share price was about 33.3429.
The adjusted shares began trading on Aug 10, 2017. This was ScinoPharm Taiwan Ltd's 6th stock split, following the previous one in Aug 10, 2016.
WKSP
NAYA
300803
WKHS
ScinoPharm Taiwan Ltd
Glance View
ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. The company is headquartered in Tainan, Tainan. The company went IPO on 2010-10-29. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The firm is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The firm operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
You don't have any saved screeners yet